Plain-English translation of NCT07837934 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether a medication called colchicine can help prevent heart disease and stroke in people with type 2 diabetes. Colchicine is an older medication that has been used to treat gout, but recent research suggests it may also calm down harmful inflammation in blood vessels. Researchers want to see if giving this medication daily can slow down the buildup of plaque in arteries.
People with type 2 diabetes have a much higher risk of heart attacks and strokes than people without diabetes, even when they're taking medications to control their blood sugar and cholesterol. Scientists believe that chronic inflammation in the body plays a big role in this extra risk, and this medication might help by reducing that inflammation.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take either the medication or a placebo (a pill with no active ingredient) once daily for 24 weeks, in addition to your regular diabetes and heart disease prevention medications. During the study, you'll have tests to check how your blood vessels are doing, including ultrasound scans of your arteries and blood tests to measure inflammation. Your doctors will monitor your safety throughout the study.
AI-generated summary from trial data · Oct 5, 2026 · Not medical advice
Singapore